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Small strongyles (Nematoda, Strongylida) or “cyatho-
stomins” have been reported from horses worldwide.
They are highly prevalent in equine populations
regardless of climatic or management differences, and
seem equally at home in horses in the tropics as in
temperate or cold climates [1-3]. Concerns have been
raised in many aspects of managing cyathostomin
challenges in horses, ranging from increasing prevalence,
resistance to anthelmintic drugs and how to prevent and
manage the clinical syndrome of larval cyathostominosis.
There are more than 50 species of cyathostomins
recognised [1,4] with some 10 species reported to be the
most prevalent. They are today the most common and
pathogenically significant parasite to affect horses around
the world [3,5,6].
Although much has been written about the prevalence
[3,5,7-13] and dangers of these nematodes, a brief review
of their biology and clinical significance can be useful in
understanding the need for developing appropriate and
effective anthelmintic strategies to best protect horses
from these highly pathogenic invaders.
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Abstract
The small strongyles of horses, also known as cyathostomins, are considered the most prevalent
and pathogenic parasites of horses today.The clinical syndrome of larval cyathostominosis which
occurs as a result of mass emergence of inhibited stages has a high fatality rate despite the best
standard of care given to affected horses. Management of the challenge level of cyathostomins to
prevent the syndrome is preferable.Many different management programmes have been tried over
the past two decades, with mixed success. Programmes have relied heavily on repeated use of
anthelmintic treatments throughout the life of a horse.The widespread incidence of resistance to
certain anthelmintics is reducing these options.An understanding of the biology of cyathostomins,
risk factors for infection and appropriate strategic use of still effective anthelmintics is essential for
the future management of this parasite group.This review highlights the necessity to use currently
available anthelmintics that are appropriately suited to the biology of cyathostomins, and to
maintain heir efficacy through an appropriate treatment strategy.
Open AccessLife-cycle and epidemiology
Cyathostomins are commonly known as “small red-
worms” due to the fact that they are usually less than
2.5 cm in length, and sometimes appear more red than
white in colour. Like many other nematodes, cyatho-
stomins have a direct lifecycle, with no intermediate host.
A schematic description of the life cycle of cyathostomins
is presented in Figure 1. Cyathostomins enter the intes-
tine at the third larval stage (L3) which has developed
from eggs passed through the faeces onto pasture land.
Once ingested by the horse, they continue their
maturation and, in a “fast” life cycle, new eggs may be
passed in the faeces onto the pasture within 5-6 weeks.
The rate of development from the first larval stage (L1) to
L3 stage is directly proportionate to temperature: in warm
weather, eggs can hatch and yield infective L3 in as little
as 3 days. Once they reach the L3 stage, they become
surrounded by a protective membrane, and can survive
well even in freezing conditions, which means that they
have the ability to remain on the pasture for a prolonged
period. In the case of experimental infections, the
development time of infections could be influenced by
chilling the larvae, or by administering a trickle infection
rather than a single infection. In the case of a single
infection, the mean pre-patent period was 53 days with a
range of 48 to 62 days, while with trickle infection the
mean pre-patent period was 65 days with a range of 60 to
77 days [14].
Moreover, cyathostomins differ from other worm species
in that the maturation of the early third larval stage (EL3)
might be arrested for a prolonged period of time. After
ingestion, the L3 ex-sheath and invades the mucosa of the
large intestine. Once inside, the larval stages protect
themselves by becoming encysted. In fact, up to 90% of
encysted cyathostomins may become “inhibited” in their
EL3 stage of development [4], and can remain within the
intestinal wall for periods ranging from about 4 months
to as long as 2 years.
The season during which inhibition occurs varies depen-
dent on climate. In temperate climates accumulation of
larvae will occur during the grazing season, the larvae will
encyst during the cooler months of the year, and may
emerge en-masse as the weather warms up in spring. The
reverse timing is seen in tropical climates, where the most
likely timing for inhibition is during the stressful, hot
summer months, with larval emergence in autumn [15].
Therefore, small strongyles have the ability to survive
both on the pasture and inside the horse for very long
periods of time, and effective, sustainable management
and treatment programmes need to take into
consideration the climatic conditions and lifecycle.
The important epidemiological risk factors for infection
with cyathostomins have been identified as age, season
and time since last deworming [16]. Interestingly, access
to grazing and shared grazing with other horses were only
weakly associated with cyathostominosis.
Species prevalence
While the classification of small strongyle species of
horses has been the subject of some discussion, there is
general agreement that more than 50 species may be
involved in parasitism of horses. Identification of species
is usually performed on adult rather than larval stages,
although in more recent times in vitro testing based on
genotype has been developed [17].
Information is available on the most prevalent species of
cyathostomins from a number of continents [3,5,7,9,18]
and from differing climatic regions within continents.
Often, cyathostomins were present in the majority of
horses surveyed (>70% to 100%) with multiple species
present in individual animals. The number of species
ranged from a few to up to 26, but there was a remarkable
similarity in the predominant species, regardless of geo-
graphy. For example, Cyathostomum catinatum, Cylicocyclus
nassatus and Cylicostephanus longibursatus were found to be
amongst the most prevalent five species in France,
Ukraine, US and Australia. C. nassatus was also common
in Brazil. Other species that were widely recognized
included Cylicostephanus minutus, Cylicostephanus calicatus
and Cyathostomum insigne. Ambient temperature does not
appear to be a significant factor in species distribution, as
the mix of species reported from tropical and temperate
climatic zones in Australia was very similar [3,9].
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Figure 1
Life cycle of cyathostomins.Little is understood about the relative pathogenicity of
individual species, or what determines the balance of
species in any mixed population. Some species are known
to predominantly reside in the colon, while others seem
to prefer the caecum [19]. Little is also known about
individual species’ lifecycles in terms of patency period,
although it has been reported that those species residing
in the caecum appear later in the faeces than species
residing in the colon [20].
Clinical significance
Small strongyles also have a remarkable ability to be
pathogenic to the horse from the moment that they enter
its gut. In common with other nematodes, large numbers
of adult worms may cause clinical symptoms such as
lethargy, sudden weight loss, debilitation, and diarrhoea.
However, cyathostomin larval stages can cause even more
serious problems. At the start of their invasion, the ex-
sheathed L3 may cause serious damage to the intestinal
mucosa. Once at the encysted stage, tens of thousands of
encysted larvae may literally cover the mucosa wall,
severely damaging it and greatly reducing nutritional
metabolism [5]. The wall of the cyst protects the larva,
and thus it may be unaffected by conventional
dewormers.
But the most devastating damage can arise from the
developed L4 stage when it emerges from the cyst and
continues its development to the adult stage in the
intestinal lumen. This usually occurs in the late winter or
early spring, when enormous numbers of larvae emerge
into the gut lumen en masse. This condition, known as
“larval cyathostominosis”, can severely damage the gut
wall, with a resultant diarrhoea, potentially serious colic,
and a mortality rate as high as 50% [21-29]. Granulo-
matous colitis has also been reported associated with
small strongyle larvae [30].
Although young horses are most vulnerable [6], it is
important to note that there is a lifelong susceptibility to
cyathostomins, and that they can cause clinical disease in
any age of horse during any season [31]. Because
cyathostomins can be pathogenic both at penetration into
and emergence from the large intestinal mucosa, it is
essential that both incoming and encysted larvae are
effectively eliminated. In the case of the encysted cyatho-
stomins, their potentially long arrested development may
be influenced by a larger larval challenge dose and how
many grazing seasons have been experienced [31].
Clinical and histo-pathological diagnosis
Since the clinical signs and clinical pathology associated
with cyathostomins are not specific and are similar to a
number of other conditions, diagnosis can be challen-
ging. However, a rapid diagnosis is a necessity if appro-
priate treatments are to be administered with due speed,
as this can be a condition with high mortality. Unfor-
tunately, many times a diagnosis may only be arrived post
mortem [32]. Affected horses may be of any age and
present with any of the following signs: chronic diarrhoea,
oedema, anorexia, dullness, acute weight loss pyrexia
[24,33]. Similarly haematology is not diagnostic.
A typical clinical picture includes neutrophilia, hypo-
albuminaemia, hyperglobulinaemia, especially beta-
globulin, all are findings that are consistent with a
protein-losing enteropathy. Low total serum protein has
been reported, as well as slightly high total protein
[33,34], possibly a result of dehydration. Diagnosis based
on clinical and haematological findings includes a horse
presenting in poor condition with diarrhoea, a serum
albumin concentration of less than 20 g/L and a ratio of
albumin:globulin of less than 0.7. Such a case is very
likely to be infected with adult and L4 stages of
cyathostomins [35]. There may be anaemia with or
without eosinophilia and/or lymphocytosis [22] One
useful diagnostic finding is the presence of large numbers
of cyathostomin larvae in faeces, but their absence does
not necessarily rule out cyathostomins as a cause of the
clinical condition [21,35].
Necropsy findings show inflammation of colon and/or
caecum, in the acute stage there is marked mucosal
hyperaemia, haemorrhage, congestion, ulceration or
necrosis. In more chronic cases there may be only some
mucosal thickening due to oedema, and irregular areas of
congestion. Numerous small strongyle larvae can be seen
in the mucosa on careful inspection. Transillumination
using a powerful lights source from the serosal surface
will aid their detection [21].
On histopathology, a cellular and inflammatory response
will be seen including mixed populations of
mononuclear cells, eosinophils and epithelial cells. The
response may focus around the larvae in the submucosa,
or may be more diffuse involving the mucosal lamina
propria as well as the submucosa [21].
Current control measures
Without a doubt, managing the level of small strongyle
challenge, particularly the avoidance of the larval cyatho-
stominosis syndrome, is the preferred path. Treatment of
clinical cases can be protracted, difficult and unrewarding,
with mortality rates of 40-70% reported even with
aggressive treatment.
The plethora of publications describing possible control
measures are a testament that control is difficult, that
there is no one programme that can be used under all
circumstances but that control practices need to be
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measures inevitably involve the use of anthelmintics,
however, the ever increasing prevalence of resistance adds
another level of difficulty to designing appropriate
control programmes.
It is therefore advisable to use an anthelmintic with a high
efficacy that will substantially reduce larval pasture
burdens, and one which is proven to be effective against
encysted cyathostomins. It is only with the best weapons
and an effective strategy that the challenge of combating
these highly pathogenic invaders can be achieved.
Over the past 20 years, management of cyathostomins
has relied heavily on the repeated use of anthelmintic
drugs. Various drug treatment regimens have been
recommended, often recommending set interval
treatments without regard to drug properties, age of
horses [36,37] or epidemiology of the cyathostomins,
and attempts have been made to address better control
strategies [38-43].
The objectives of effective control programmes should
address measures to reduce the numbers of infective
larvae on pastures and to reduce the number of
anthelmintic treatments required to achieve this egg
reduction as a means of delaying or avoiding drug
resistance in the cyathostomin population [44].
There are three available drug classes for cyathostomin
control in horses, the benzimidazoles such as fenbenda-
zole and oxfendazole, the tetrahydropyrimidines which
are the pyrantel salts, and the macrocyclic lactones (ML),
ivermectin and moxidectin. All of these drugs have
differing levels of efficacy, duration of activity and
spectrum of stages of cyathostomins they control. The ML
class of drugs has become ever more widely used due to
their potency, spectrum of activity, relative safety, and as
yet few reports of resistance.
In the case of fenbendazole, the recommended dose of
5 mg/Kg liveweight will control sensitive strains of adult
and developing larval stages of small strongyles. For
control of inhibited stages a daily dose of 10 mg/Kg
liveweight for 5 consecutive days is recommended.
Fenbendazole resistance has been recognised as being
widespread in all major horse populations surveyed and
use of this compound at either dosage regimen should be
avoided where resistance occurs [45-51].
Treatment regimens with pyrantel salts have varied, and
include recommendations for monthly treatments, or
even daily administration which was adopted in horse
operation the US for many years, although this
programme did not find favour in other geographies.
Pyrantel salts are not effective against inhibited stages of
small strongyles but will remove sensitive strains of
adults. Resistance to pyrantel salts has been identified
both in Europe and the US, but does not appear to be as
widespread as resistance to benzimidazoles [52-57].
As a general caution, unless sensitivity has been demon-
strated by a faecal egg count reduction test, use of
benzimidazole or pyrantel based anthelmintics carries the
risk that treatment will be ineffective [58-61].
The two compounds within the macrocyclic lactone
group need to be considered separately due to significant
differences in potency and spectrum. The first available
ML for horse, ivermectin, is highly potent against adult
stages, luminal larval stages and developing stages of
larvae in mucosa, but has variable and low efficacy against
inhibited stages, even when elevated doses (5X) are
administered [62-64].
Moxidectin, in addition to having high efficacy against all
cyathostomin stages given as a single dose at a rate of
0.4 mg/Kg liveweight [62-66] also provides persistent
activity against re-infection by small strongyles [67],
resulting in a long egg re-appearance interval. The
required re-treatment interval with moxidectin is longer
than that for other anthelmintics allowing less frequent
treatment and less selection for resistance [44,57,68-75].
The effects of removal of luminal stages of parasites on
emergence of inhibited stages, whether by anthelmintic
treatment or natural expulsion, must also be taken into
account when designing new approaches to cyathostomin
control programmes [76]. Another factor of importance
to clinicians is the consequence of killing the inhibited
stages, as it has been reported that the die-off of these
stages following fenbendazole treatment results in severe
inflammation of the mucosa of the colon. In the same
study, inflammation was not seen subsequent to the
elimination of these stages using moxidectin [77].
Conclusion
We are fortunate that the last two decades have seen a
large body of research, information and understanding of
the complex issues surrounding the life cycle, clinical
significance and control of small strongyles in horses. We
have the opportunity to apply this knowledge to develop
better control programmes than have been implemented
in the past.
Monahan summed the situation well by stating in 2000:
“Rote memorization of treatment schedules and anti-
parasitic drugs without understanding the biology of the
worms to be controlled concedes any intellectual advan-
tage to the worms” [44].
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